Botulinum neurotoxin (BoNT) is a potent and specific biomolecule that is both implicated as a potential threat in bioterrorism and used in therapeutics. Highly sensitive and robust assays that measure BoNT activity are needed to manage outbreak or controlled distribution of BoNT. Current in vivo and in vitro assays have limitations, including high costs and variability for mouse bioassays, extensive preparations for primary and stem cell-derived neurons, and inherent low sensitivity for cell lines. Sensitivity of cell lines can be increased by direct differentiation and with their physiological relevance (compared with cell-free strategies) and robustness (compared with primary cell strategies); adopting cell lines is an attractive alternative to in vivo assays. Here, we present two distinct strategies that improved sensitivity of a cell line to BoNT serotype A (BoNT/A) without direct differentiation. We developed a cell-based BoNT assay using microscale culture and coculture of neuronal and Schwann cell lines, NG108-15 and S16, respectively, to improve both sensitivity and physiological relevance. Results showed that NG108-15 and S16 coculture decreased EC 50 from 12.5 to 0.8 ng/µl (p < 0.001) in macroscale and from 2.6 to 1.1 ng/µl (p = 0.006) in microscale. In addition, NG108-15 monoculture at microscale decreased EC 50 from 12.5 to 2.6 ng/µl (p < 0.001) compared with macroscale. Finally, controlling the spatial arrangement of microscale coculture revealed that S16-derived soluble factors can increase sensitivity. Thus, our study demonstrates two distinct strategies for increasing the sensitivity of a cell line to BoNT using coculture and microscale culture, thereby advancing assay technology for BoNT detection.
Botulinum neurotoxin (BoNT) is an N-terminal zinc-metalloprotease consisting of seven serotypes (A-G) that are produced by the bacterium species Clostridium botulinum (Montal, 2010) . BoNT is well known for its clinical efficacy in both cosmetics and neuromuscular distonias (Chaddock and Acharya, 2011) , achieved via the blocking of acetylcholine release (Kao et al., 1976) . Additionally, BoNT is known for its extremely high specific toxicity, which together with its ease of production makes it a serious threat in bioterrorism (Arnon et al., 2001) . Understanding the effects of BoNT on neural response and function, as well as the mechanisms underlying BoNT-associated cell signaling, is crucial to our ability to both harness its useful application in clinical settings and control its potential danger to public health and safety.
In vivo, BoNT activity occurs specifically at the presynaptic ends of neuromuscular junctions (NMJs), a complex cellular microenvironment primarily comprised the axon terminal of a motor neuron forming a synapse with a skeletal muscle fiber, which is further capped by terminal Schwann cells and kranocytes (Thomson et al., 2012) . Although motor neurons and muscle fibers are the fundamental units of NMJs, terminal Schwann cells also play an essential role in the microenvironment by being involved in synaptogenesis, synaptic activity, regeneration of damaged synapses, and synaptic maturation of NMJs (Eroglu and Barres, 2010; Thomson et al., 2012) . Thus, the behavior and function of neurons at an NMJ, including their response to BoNT, are likely dependent on the complex microenvironmental cues at the NMJ, particularly signals provided by neighboring cell types.
BoNTs consist of covalently linked ~100 kDa heavychain (HC) and catalytic ~50 kDa light-chain (LC) domains. The HC binds two different types of surface receptors, polysialogangliosides and cell surface protein receptors, which are present at postsynaptic ends of cholinergic neurons and are responsible for internalizing BoNT into the cell by endocytosis Disclaimer: The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication. toxicological sciences 134(1), 64-72 2013 doi:10 .1093/toxsci/kft082 Advance Access publication April 5, 2013 in active synapses. The LC is delivered into the cytosol through a channel in the endocytotic vesicle formed by the N terminus of the HC. The LC then cleaves a specific peptide bond in a protein of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex, blocking the release of neurotransmitters (Kao et al., 1976; Montal, 2010) . BoNT serotypes A and E cleave synaptosome-associated protein 25 (SNAP25); serotypes B, D, F, and G cleave synaptobrevin on synaptic vesicles; and serotype C cleaves both SNAP25 and syntaxin on the plasma membrane (Montal, 2010) . Because of the high degree of specificity in cleavage of SNARE proteins by BoNTs, many assays have been developed to measure SNARE cleavage to detect and quantify toxicity of BoNT (Hakami et al., 2010) .
Currently available BoNT assays can be divided into four basic categories: (1) in vitro cell-free, (2) in vitro cell-based, (3) ex vivo, and (4) in vivo assays (Hakami et al., 2010) . Ex vivo and in vivo assays, including the standard in vivo mouse bioassay (also known as in vivo mouse LD 50 assay), are highly sensitive and physiologically relevant models but suffer from high cost, low throughput, high variability, and various practical and ethical issues related to animal testing (Cai et al., 2007) . In contrast, although in vitro cell-free assays such as enzymelinked immunoabsorbent assay (Phillips and Abbott, 2008) and synthetic SNAP25 substrate peptide cleavage assay in microfluidic channel (Frisk et al., 2009 ) are very sensitive and high throughput methods (Bagramyan et al., 2008) , these assays do not measure all relevant steps for intoxication disregarding important physiological mechanisms (Pancrazio et al., 1999) . Although in vitro cell-free assays do not capture physiological mechanisms, they are useful in positive and negative testing for BoNT, where cell culture and animal care facilities are not accessible.
Cell-based assays are attractive because they represent living functional units that exhibit physiological mechanisms, but have lower cost and can be better standardized than in vivo methods (Cai et al., 2007) . Therefore, cell-based assays are great alternatives to in vivo mouse bioassay in determining specific toxicity of BoNT for pharmaceutical applications. Despite high sensitivity and physiological relevance, cell-based assays relying on fastidious primary (Pellett et al., 2010) and stem cell-derived neurons (Pellett et al., 2011; Whitemarsh et al., 2012b) are difficult to isolate and require several weeks of cell culture before they can be used for BoNT detection. In the past, studies had demonstrated utility of neuronal cell lines in detecting BoNTs but they suffered from low sensitivity (Purkiss et al., 2001; Yowler et al., 2002) . Recently, however, direct differentiation of neuronal cell lines using soluble factors achieved high sensitivity of the cell lines (Fernández-Salas et al., 2012; Whitemarsh et al., 2012a) . Alternatively, an in vitro cell-based assay that labeled different SNARE substrates with fluorescence resonance energy transfer (FRET) sensors in cells has shown promise for higher throughput and multiplex potential (Dong et al., 2004) , but challenges associated with widespread accessibility and technical difficulties in detecting the FRET signal still remain. Importantly, a limitation of current cell-based assays, which has been largely overlooked, is that they do not account for many critical aspects of the NMJ microenvironment, such as the presence and putative role of Schwann cells (Reddy et al., 2003) , and the importance of controlling diffusion that affects cell signaling through soluble factors Paguirigan and Beebe, 2009) to more closely mimic physiological conditions (Young and Beebe, 2010) . It is possible that improvements in the design and control of the in vitro microenvironment may increase sensitivity of BoNT detection by addressing the key issues related to current in vitro cell-based platforms and thus offer an alternative to existing assays.
Recent advances in microfluidic cell-based technologies have provided a unique opportunity to test this hypothesis. Microscale cellular systems leverage microfabrication techniques to yield customized geometries that improve spatiotemporal control of the microenvironment, including the organization of different cell types and improved control of soluble factor diffusion. Here, we describe a microscale coculture model consisting of neurons and Schwann cells that recapitulate important aspects of the cellular interactions of the NMJ microenvironment, with specific application to the detection of BoNT. As a baseline for the microscale experiments, we first tested macroscale coculture of the neuronal NG108-15 with S16 Schwann cell lines and discovered that it significantly increased sensitivity compared with that of NG108-15 monoculture. We further found that culturing at the microscale versus macroscale in the absence of S16 cells has significant effects on sensitivity and that through the spatial arrangement of NG108-15 and S16 cells in microenvironments, soluble factors from the S16 cells are the likely contributors to the increased BoNT serotype A (BoNT/A) sensitivity observed.
MATERIAlS AND METHoDS
Cell lines and cell culture. A hybrid mouse neuroblastoma and rat glioma cell line, NG108-15, was purchased from ATCC (Manassas, VA); maintained in growth medium composed of Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, CA) with 10% fetal bovine serum (FBS; Invitrogen) and 1% penicillin-streptomycin (P/S; Invitrogen); and supplemented with 0.1 mM hypoxanthine, 400 nM aminopterin, and 16 μM thymidine (HAT; Sigma-Aldrich, St Louis, MO). A rat Schwann cell line, S16, was purchased from ATCC; cultured in T-75 flasks coated with poly-l-lysine (PLL; SigmaAldrich); and maintained in growth medium composed of DMEM with 10% FBS, 1% P/S, and 110 mg/l sodium pyruvate (Sigma-Aldrich). Both NG108-15 and S16 cells were incubated at 37°C with 5.0% CO 2 , subcultured as suggested by the supplier, and discarded after 20 passages. S16 conditioned medium. As described previously, 3 × 10 5 S16 cells were cultured in PLL-coated T-75 flasks in the S16 growth medium. Cells were washed with PBS after 1 day of culture and then fed with 20 ml of fresh supplemented S16 growth medium free of FBS. After 3 additional days of culture without media exchange, conditioned medium (CM) was collected and centrifuged for 10 min at 2000 rpm, and supernatant was stored at −20°C until ready for use. For CM experiment at the macroscale, 50 μl of CM was mixed MICROSCALE AND COCULTURE BONT DETECTION MODEL with 150 μl of fresh serum-free NG108-15 growth medium. FBS was then added subsequently to make 1% FBS by volume. Thus, the overall dilution of the soluble factors in CM was approximately 270 nl/cell (20 ml per 300,000 cells followed by 1:4 dilution).
Microfluidic device design.
The microfluidic device consisted of a 3 × 4 array of independent microculture systems, each consisting of three separate microchambers connected by diffusion ports (Fig. 1A) . The device design allowed independent experimental conditions in each microculture system, whereas the interconnected design of the microculture system allowed cellcell communication via soluble factors without the influence of physical cues. Details of design and operation are described elsewhere (Young et al., 2012) . For all microscale coculture experiments in this study, NG108-15 cells were seeded in the middle microchamber, and S16 cells were seeded in either the two side microchambers or in the middle mixed with NG108-15 cells (Fig. 1B) . Cells, medium, BoNT/A, and fixing and immunostaining reagents were all introduced into the microchambers by passive pumping using only a micropipettor (Walker and Beebe, 2002) .
Microfluidic device fabrication. The microfluidic device was fabricated using established soft lithography techniques (Duffy et al., 1998; Xia and Whitesides, 1998) . Briefly, master molds were made by spin coating different grades of SU-8 (Microchem, Bedford, MA) followed by prebake, ultraviolet light exposure, postbake, and development steps. Polydimethylsiloxane (PDMS; Dow Corning, Midland, MI) was mixed in a 10:1 ratio of prepolymer base and crosslinking agent, vacuumed, poured on the master molds, and cured at 80°C for 4 h on a hot plate. Cured PDMS layers were then removed from the master molds, and soxhlet-extracted with 100% ethanol for at least 4 h to remove uncrosslinked PDMS oligomers known to leach from the bulk into culture media (Regehr et al., 2009) . PDMS layers and a glass slide were sequentially plasma treated and irreversibly bonded, as described previously (Young et al., 2012) . The assembled device was heated at 70°C for 10 min on a hot plate prior to use.
Immunofluorescence microscopy. Antibodies used include the following: for primary antibodies, mouse monoclonal IgG anti-SNAP25 (Synaptic Systems, Gottingen, Germany) and rabbit polyclonal IgG anti-S100 (Thermo Scientific, Rockford, IL); for secondary antibodies, AlexaFluor488 goat antimouse and AlexaFluor647 goat anti-rabbit (Invitrogen). 4′,6-Diamidino-2-phenylindole (DAPI) nuclear staining dye was acquired from Invitrogen. Cells were fixed with 4% paraformaldehyde prior to staining. Both S100 and SNAP25 primary antibodies were diluted 1:200 in 1% bovine serum albumin (BSA; Sigma-Aldrich), incubated overnight at 4°C. The secondary antibodies were diluted 1:500 in 1% BSA and incubated for 30 min at ambient. For all staining and washing, passive pumping was used. Fluorescence microscopy was performed on a Nikon Eclipse Ti inverted fluorescence microscope with a PlanFluor ×4 or ×20 objective (Nikon Instruments, Melville, NY), and images were captured with a Nikon DS-Qil Mc CCD camera and acquired with NISElement Version D 3.10 software.
Microscale cell viability assay. Cells were cultured in the microchambers as described previously. Cells were washed with PBS (with Ca 2+ /Mg 2+ ) 2 days after seeding and incubated at ambient temperature for 20 min with a Live/Dead cytotoxicity assay (Invitrogen) consisting of Calcein AM (green) for live cells and ethidium homodimer-1 for dead cells. DAPI was added to the samples after washing the cells. Nikon Eclipse Ti inverted fluorescent microscope with PlanFluor ×4 objective and additional ×1.5 intermediate magnification was used for image acquisition. Cell viability assay was performed in triplicates.
Macroscale SNAP25 cleavage toxicity assay. Each well of a 96-well plate (Becton Dickinson and Company, Franklin Lakes, NJ) was coated with 50 µl of 0.083 mg/ml Matrigel (BD Bioscience, San Jose, CA) prior to cell seeding. Each well was seeded with ~15,000 NG108-15 cells either alone or with ~3750 or ~15,000 S16 cells. Cells were cultured for 2 days in 200 μl of DMEM with 1% FBS, 1% P/S, and HAT. BoNT/A at 8 U/pg specific toxicity was serially diluted in culture medium to the desired concentration, and 50 μl of the diluted BoNT/A was added to each well after aspirating spent medium. Cells were collected for Western blot 2 days after treatment. All materials that contacted BoNT/A were disinfected with 10% household bleach before disposal.
FIG. 1.
Design of the microfluidic device: (A) 3D view of the microculture system; (B) image of the device with 3 × 4 array of microculture systems; and (C) top view of a microculture system consisting of three microchambers, one in the middle and two on each side; side view of the microculture system with arrow indicating the direction of flow by passive pumping; front view of the device where NG108-15 cells were seeded in the middle and S16 cells in the side microchambers. Diffusion ports were placed approximately 250 μm above the glass surface where cells adhered. Scale bars on cell images represent 100 μm.
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Microscale SNAP25 cleavage toxicity assay. Microculture systems were filled with 70% ethanol, coated with PLL, washed three times with sterile deionized water, and coated with 30 µl of 0.083 mg/ml Matrigel. For monoculture and mixed coculture, ~15,000 NG108-15 cells were seeded either alone or mixed with ~15,000 S16 cells in the middle microchamber using passive pumping. For compartmentalized coculture, ~15,000 NG108-15 cells were seeded in the middle microchamber and ~1875 or ~7500 S16 cells were seeded in both side microchambers totaling ~3750 or ~15,000 S16 cells per microculture system. Spent medium was aspirated and 30 μl of fresh medium (FM) was added daily for 2 days. BoNT/A was diluted to desired concentration in the medium and 30 μl of the BoNT/A (10 μl in each microchamber) was added to each microculture system after aspirating spent medium. Two days after BoNT/A treatment, 10 μl of 2× lithium dodecyl sulfate (LDS) buffer (Invitrogen) was directly added to the middle microchambers via passive pumping and then collected. This lysis and collection step was repeated once. All materials that contacted BoNT/A were disinfected with 10% household bleach before disposal.
Western blot. LDS was added directly to the BoNT/A-treated cells and heated for 10 min at 70-80°C. Samples were loaded onto a 12% Bis-Tris gel (Invitrogen) and electrophoretically separated in SDS MOPS buffer (Invitrogen) by applying 200 V for 75 min. The gel was transferred onto a Mini Nitrocellulose Transfer Pack by Trans-Blot Turbo Transfer System (Bio-Rad, Hercules, CA). The blot was stained with mouse monoclonal IgG anti-SNAP25 (Synaptic Systems) and rabbit polyclonal IgG anti-β-actin (Thermo Scientific) primary antibodies. Antimouse IRDye800 and antirabbit IRDye700 (LiCor, Lincoln, NE) IgG secondary antibodies were used for detection with a LICOR Odyssey two-channel infrared imager (LiCor). An optical densitometry tool from ImageJ (NIH) was used to quantify relative ratio of cleaved to uncleaved SNAP25. The half maximal effective concentration (EC 50 ) for each sigmoidal curve was calculated using GraphPad Prism 5 software (GraphPad, La Jolla, CA).
Statistical analysis. For all of the EC 50 comparisons, log-transformed one-way ANOVA followed by Tukey method were performed using R software version 2.12.1 (*p < 0.05; **p < 0.01; ***p < 0.001). All error bars represent standard error.
RESulTS

Macroscale SNAP25 Cleavage Toxicity Assay in 96-Well Plate
To verify that the NG108-15 cell line used was functional for BoNT/A internalization and SNAP25 cleavage, we first demonstrated that NG108-15 cells expressed both SNAP25 and SV2A by Western blotting (Supplementary figs. 1A and B) . In contrast, S16 cells were shown not to express either SNAP25 or SV2A, as expected. To determine BoNT/A sensitivity of NG108-15 cells at the macroscale, we cultured NG108-15 cells in 96-well plates, either in monoculture or in coculture with S16 cells, and measured SNAP25 cleavage by Western blotting. BoNT/A was found to cleave SNAP25 in a dose-dependent manner, with an EC 50 of 12.5 ng/µl ( Figs. 2A-C) . To test our hypothesis that culturing neurons with Schwann cells would increase assay sensitivity by creating a more physiological NMJ microenvironment, we cocultured ~15,000 NG108-15 cells with either ~3750 or ~15,000 S16 cells (ie, 4:1 and 1:1 NG108-15-to-S16 cell ratio). In cocultures, EC 50 decreased to 5.1 ng/µl for 4:1 cell ratio and further decreased to 0.8 ng/µl for 1:1 cell ratio ( Figs. 2A-C) . This represented a 16-fold increase in sensitivity compared with monoculture of NG108-15 cells. Because these cocultures were performed in wells without compartmentalization of cell types, it is possible that soluble factor, physical factor, or a combination of both was responsible for the measured increase in sensitivity. To decouple the effects The concentration of BoNT/A required to cleave 50% of SNAP25, denoted as EC 50 . NG108-15 monoculture ((NG)), closed circle; NG108-15 and S16 coculture at 4:1 cell ratio in the same well ((NG&S16) 4:1), closed triangle; NG108-15 and S16 cocultured at 1:1 cell ratio in the same well ((NG&S16) 1:1), closed square; NG108-15 cultured in S16 CM ((NG&S16CM)), open triangle. P-values (*p < 0.05; **p < 0.01; ***p < 0.001) of the three independently repeated experiments (n = 3). of chemical and physical signals from S16 cells, serum-free S16-CM was mixed with FM in 1:3 CM-to-FM volume ratio and used to culture NG108-15 cells alone. In CM experiments, we found that EC 50 decreased slightly to 8.8 ng/µl (Figs. 2A-C) but without statistical significance (p = 0.622).
Cell Viability and Characterization in Microculture Systems
Similar EC 50 between monoculture and CM condition suggested that both contact and soluble factors regulate sensitivity of NG108-15 cells. However, it is also possible that the reduced effects of S16-derived CM compared with direct coculture of S16 cells with NG108-15 cells at the macroscale may have been due to (1) high dilution of the soluble factors from S16-derived CM prepared in large T-75 flasks or (2) potential loss or degradation of soluble factors from freezing and thawing samples and additional liquid handling. To reduce these issues related to CM-based experiments, we used a microculture system that compartmentalized the two cell types to eliminate physical contact and allow communication via soluble factors only (Fig. 1 ).
An independent microculture system consisted of three separate cell culture microchambers connected by diffusion ports. To prevent cells from migrating across microchambers and contaminating compartmentalized cultures, diffusion ports were positioned ~250 μm above the glass surface where cells adhered (Fig. 1C) . Proper compartmentalization of NG108-15 and S16 cells was verified by immunofluorescence microscopy. S16 cells showed S100, which is highly expressed in glial cells (Fig. 3E ), but did not express SNAP25 (Fig. 3F, Supplementary  fig. 1A ). In contrast, NG108-15 cells expressed both S100 and SNAP25 because of their hybrid neuroblastoma/glioma phenotype (Figs. 3B and C) . Images also showed that cells remained in their respective microchambers after 2 days of culture (Figs.  3A-I ). In addition, both NG108-15 and S16 cells demonstrated high viability in the microculture systems (Figs. 4A-F) .
Microscale SNAP25 Cleavage Toxicity Assay in Microfluidic Device
To test the hypothesis that soluble factor signaling in microscale environments can improve assay sensitivity, we compared monoculture of NG108-15 cells alone at the macroscale with that of NG108-15 cells alone in microchambers, and found that EC 50 at the microscale decreased significantly to 2.6 ng/µl compared with macroscale culture in 96-well plates (Fig. 6A) . Compartmentalized microscale coculture at 4:1 cell ratio showed no significant difference in EC 50 compared with monoculture (2.2 ng/µl, p = 0.977; Figs. 5A-C). However, microscale coculture at 1:1 cell ratio, in both separate microchambers (µ(NG)(S16)) and in the same middle microchamber (µ(NG&S16)), further decreased EC 50 to 1.2 and 1.1 ng/µl, respectively (Fig. 5C) . Surprisingly, EC 50 of microscale versus macroscale coculture conditions did not show statistical difference (p = 0.692; Fig. 6B ), whereas EC 50 of microscale versus macroscale monoculture conditions did show statistical difference (Fig. 6A) . The results for EC 50 under various conditions are summarized in Table 1 .
FIG. 3.
Separation of NG108-15 and S16 cells in the microchambers. Immunofluorescence images of the microculture system stained with (A) DAPI, (D) S100, and (G) SNAP25; scale bar represents 500 μm. Higher resolution fluorescent microscope images of the middle and side microchambers seeded with NG1080-15 and S16 cells, respectively. All of the microchambers were stained with (B and C) DAPI, (E and F) S100, and (H and I) SNAP25; scale bar represents 200 μm. The experiments were done in triplicates.
TABlE 1 Relative EC 50 and Fold Increase in Sensitivity
Culture condition Macroscale Microscale NG108-15 alone 1.0 (-) 0.21 (4.9×)* NG108-15 and S16 (4:1) 0.41 (2.5×)** 0.17 (5.8×)* NG108-15 and S16 (1:1) 0.06 (16×)* 0.09 (11×)* Note. Measured EC 50 values are normalized to NG108-15 monoculture in 96-well plate, and the inverse of the normalized EC 50 was taken to calculate relative fold increase in sensitivity (within parenthesis). Microscale culture conditions where NG108-15 and S16 cells were cultured in separate microchambers were used for the calculation. *p < 0.001, **p < 0.01.
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DISCuSSIoN
There is an important need to develop assays that can detect and quantify BoNT in a sensitive and robust manner. Existing assays either suffer from high variability and poor reproducibility such as in vivo mouse bioassays or have poor physiological relevance such as in vitro cell-free assays (National Institute of Health, 2008) . On the other hand, cell lines are physiologically relevant and their inherently low sensitivity can be increased by promoting differentiation (Fernández-Salas et al., 2012; Whitemarsh et al., 2012a) . In this article, we described a microscale cell culture system that was developed to improve both sensitivity and physiological relevance simultaneously. This was achieved by making two important, distinct advances to traditional cell-based assays (1) using coculture of neurons with Schwann cells instead of monoculture of neurons alone and (2) using microscale instead of macroscale culture environments to reduce soluble factor diffusion and control spatial organization. Results from these two advances, alone and in concert, are summarized in Table 1 .
We chose to develop an assay that relied on cell lines, including the NG108-15 neuronal cell line and the S16 Schwann cell line, as opposed to fastidious primary or stem cells. Unlike primary and stem cells that require extracting tissue from animals or necessitate prolonged cell culture and differentiation steps, cell lines are readily available, easily cultured and maintained, and more robust in terms of run-to-run variability. NG108-15 cell line was previously shown to form cholinergic synapses with myotubes McGee et al., 1978) and differentiate with elevated levels of endogenous cyclic adenosine monophosphate (cAMP) and other soluble factors such as retinoic acid and purmorphamine (Nirenberg et al., 1983; Tojima et al., 2000; Whitemarsh et al., 2012a) . S16 is a well-characterized and commercially available Schwann cell line with phenotype most , open triangle; NG108-15 and S16 cocultured at 1:1 cell ratio in the separated well (μ(NG)(S16) 1:1), open square; and NG108-15 cultured in S16 cultured in the same well ((NG and S16) 1:1), closed triangle. P-values (*p < 0.05; **p < 0.01) of the three independently repeated experiments (n = 3).
MICROSCALE AND COCULTURE BONT DETECTION MODEL similar to primary cells (Hai et al., 2002) . The main drawback of employing cell lines was the lack of sensitivity prior to differentiation and nonfunctional synapses. Thus, our primary objective was to choose a cell line that forms active synapses and provide culture conditions that would improve sensitivity.
First, we compared conventional monoculture of neurons and the coculture of neurons and Schwann cells in macroscale 96-well plates and found that cocultured cells were significantly more sensitive to BoNT/A treatment than monocultured cells. This effect was enhanced with increasing density of cocultured Schwann cells, up to 16-fold more sensitive than original monoculture. The sensitivity increase was likely aided by Schwann cells' synaptogenic potential and modulation of synaptic activities, as previous reports demonstrated that Schwann cell-derived CM was enough to increase the number of synapses of rat spinal motor neurons (Ullian et al., 2004) and increase synaptic activities at the developing NMJs (Cao and Ko, 2007) . Interestingly, when CM was collected from S16 cells and applied to monocultured NG108-15 cells, the sensitivity was not significantly different than monoculture. This suggested that the soluble factor signals in the CM were either (1) acting in concert with physical signals when both cell types were cultured in the same compartment or (2) inactivated or mitigated in its effectiveness because of handling or an overly high dilution factor. Concentration of S16-derived soluble factors in coculture at 4:1 cell ratio was roughly 90-fold higher than CM culture (i.e., ~3 nl/cell in coculture compared with ~270 nl/cell in CM culture; Materials and Methods section). Based on previous evidence that soluble factors from Schwann cells were enough to induce synaptogenesis and synaptic activity, highly diluted CM likely caused the reduced effect of S16 soluble factors.
To accentuate the effect of soluble factors by reducing diffusion distances, we designed a microscale coculture system that allows improved soluble factor sensitivity by compartmentalization and by eliminating the need for CM experiments. Using the microscale NG108-15 monoculture, we observed a significant fivefold increase in sensitivity compared with macroscale NG108-15 monoculture. This increased sensitivity is due to reduced culture volume in microscale culture for a single cell type, suggesting that accentuated autocrine effects may be responsible. Interestingly, the effect of coculture on assay sensitivity at the microscale (from EC 50 of 2.6 to 1.2 ng/µl) was much less significant compared with the effect of coculture on sensitivity at the macroscale (from EC 50 of 12.5 to 0.8 ng/µl). We had hypothesized that the combination of coculture and the microscale may synergistically increase the sensitivity compared with that of either macroscale coculture or microscale monoculture alone. However, this synergistic effect did not materialize as the largest fold increase in sensitivity was achieved by macroscale coculture. Decreasing the culture scale form macro to micro showed more improvement in sensitivity than coculturing at microscale. This rather surprising result may be due to (1) the existence of a coculture "detection limit" or (2) absorption of S16-derived soluble factors into the surrounding PDMS material.
Although it is possible that the effects of coculture may reach a limit due to saturation of surface receptors that associate with S16-secreted soluble factors, this is unlikely because glial cells outnumber neurons in vertebrate nervous system. Furthermore, the sensitivity gain at 4:1 cell ratio at the microscale was insignificant (Fig. 5C) . A more likely cause for the diminished effect would be the absorption of S16-secreted soluble factors that mediate cell-cell communication and affect assay sensitivity. The microfluidic device was fabricated from PDMS, which is known to absorb hydrophobic molecules and abrogate associated cellular responses (Regehr et al., 2009) . The influence of small hydrophobic molecule absorption is further aggravated at microscale due to the increased surface-to-volume ratio. It is known that transforming growth factor-β1 (TGF-β1) associates with TGF-β-binding proteins through hydrophobic interactions (Saharinen and Keski-Oja, 2000) , and TGF-β1 is one of the secreted factors from Schwann cells that modulate synaptic activity at the developing NMJ (Feng and Ko, 2008) . Therefore, it is plausible that some of S16-secreted soluble factors were absorbed in PDMS along with TGF-β1, thereby diminishing the coculture effect at the microscale. Fabricating devices from a more bioinert material such as polystyrene or other polymers (Young et al., 2011 ) may be included in future studies to confirm our hypothesis and validate our platform for application of BoNT cell-based assay. In summary, we demonstrated proof of concept that a neuronal cell line can be sensitized by coculturing with Schwann cells and by culturing at the microscale. Further improvements could allow the assay to match or surpass the sensitivity of in vivo and primary or stem cell-derived neuron cell-based methods. For example, one potentially viable option may be to use coculture in combination with supplementing cell culture medium with gangliosides, factors that increase endogenous cAMP and differentiating the cell lines (Nirenberg et al., 1983; Whitemarsh et al., 2012a; Yowler et al., 2002) . Furthermore, alternative endpoint readouts may be considered for cell-based assays to eliminate the use of Western blots that are time consuming to perform. Continuous improvement in FRET sensor technology (Lam et al., 2012) may alleviate a major bottleneck in adopting cell-based assays. Together with our microscale coculture platform and emerging sensor technologies, robust and sensitive cell-based BoNT detection assays have potential to replace in vivo assays in the future.
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